ReShape Lifesciences Inc. (RSLS)
USD 4.5
(-4.46%)
USD 4.5
(-4.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.96 Million | -21.9 Million | -15.37 Million | -8.55 Million | -14.2 Million | -27.49 Million |
| Net Income | -11.38 Million | -46.21 Million | -61.93 Million | -21.63 Million | -74.2 Million | -35.26 Million |
| Depreciation & Amortization | 154 Thousand | 2.15 Million | 1.97 Million | 1.66 Million | 1.7 Million | 440.55 Thousand |
| Deferred income taxes | 28 Thousand | -423 Thousand | -60 Thousand | -86 Thousand | -1.14 Million | -3.44 Million |
| Stock-based compensation | 766 Thousand | 2.08 Million | 12.22 Million | 1.32 Million | 2.31 Million | 3.09 Million |
| Change in working capital | -4.13 Million | 709 Thousand | -2.74 Million | 6000.00 | -1.42 Million | 857.21 Thousand |
| Other non-cash items | -2.38 Million | 19.78 Million | 34.63 Million | 10.17 Million | 58.56 Million | 6.82 Million |
| Investing Cash Flow | -10 Thousand | -92 Thousand | 1.85 Million | -2.39 Million | -2.01 Million | -10.32 Million |
| Investments in PPE | -43 Thousand | -131 Thousand | -352 Thousand | -390 Thousand | -14 Thousand | -49.57 Thousand |
| Acquisitions | 33 Thousand | 39 Thousand | 2.2 Million | -2 Million | -2 Million | -10.27 Million |
| Investment purchases | -33 Thousand | -39 Thousand | - | - | - | -9.1 Million |
| Sales/Maturities of investments | 13.43 Million | 639 Thousand | - | - | 2.55 Million | 29.9 Million |
| Other Investing Activities | -13.4 Million | -600 Thousand | 2.2 Million | - | -2.55 Million | -20.79 Million |
| Financing Cash Flow | 17.57 Million | 3.13 Million | 33.29 Million | 11.07 Million | 13.65 Million | 33.2 Million |
| Debt repayment | - | - | -10.5 Million | -10.39 Million | -10 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -500 Thousand |
| Common Stock Issuance | 17.57 Million | 639 Thousand | 2.81 Million | 679 Thousand | 23.37 Million | 10.02 Million |
| Other Financing Activities | 17.57 Million | 2.49 Million | 40.98 Million | 20.79 Million | 13.65 Million | 33.2 Million |
| Accounts receivables | 125 Thousand | 678 Thousand | -284 Thousand | 285 Thousand | 585 Thousand | -507.89 Thousand |
| Accounts payables | -3.45 Million | 448 Thousand | -1.48 Million | -33 Thousand | -543 Thousand | 317.08 Thousand |
| Inventory | -465 Thousand | -1.18 Million | -369 Thousand | -1.17 Million | -332 Thousand | 1.97 Million |
| Other working capital | -337 Thousand | 770 Thousand | -608 Thousand | 929 Thousand | -1.13 Million | -929.62 Thousand |
| Cash at beginning of period | 3.95 Million | 22.81 Million | 3 Million | 2.98 Million | 5.54 Million | 10.16 Million |
| Cash at end of period | 4.55 Million | 3.95 Million | 22.81 Million | 3 Million | 2.98 Million | 5.54 Million |
| Capital Expenditure | -43 Thousand | -131 Thousand | -352 Thousand | -390 Thousand | -14 Thousand | -49.57 Thousand |
| Effect of forex changes on cash | - | 4000.00 | 29 Thousand | -113 Thousand | -8000.00 | - |
| Net cash flow / Change in cash | 604 Thousand | -18.86 Million | 19.8 Million | 22 Thousand | -2.56 Million | -4.61 Million |
| Free Cash Flow | -17 Million | -22.03 Million | -15.72 Million | -8.94 Million | -14.21 Million | -27.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.59 Million | -2.19 Million | -11.38 Million | -1.69 Million | -3.53 Million | -3.49 Million |
| Depreciation & Amortization | 6000.00 | 6000.00 | 154 Thousand | 7000.00 | 50 Thousand | 49 Thousand |
| Deferred income taxes | 15 Thousand | 1000.00 | 28 Thousand | 27 Thousand | 2000.00 | 4000.00 |
| Stock-based compensation | 65 Thousand | 72 Thousand | 766 Thousand | 110 Thousand | 216 Thousand | 218 Thousand |
| Change in working capital | 258 Thousand | 454 Thousand | -4.13 Million | -761 Thousand | -218 Thousand | -3.1 Million |
| Other non-cash items | -194 Thousand | -829 Thousand | -2.38 Million | -142 Thousand | 704 Thousand | -332 Thousand |
| Investing Cash Flow | - | - | -10 Thousand | 3.2 Million | - | -3000.00 |
| Investments in PPE | - | - | -43 Thousand | - | - | -36 Thousand |
| Acquisitions | - | - | 33 Thousand | -33 Thousand | - | 33 Thousand |
| Investment purchases | - | - | -33 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | 13.43 Million | 3.23 Million | - | - |
| Other Investing Activities | - | - | -13.4 Million | - | - | 33 Thousand |
| Financing Cash Flow | 24 Thousand | - | 17.57 Million | 5.46 Million | -338 Thousand | 2.25 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 24 Thousand | - | 17.57 Million | 5.46 Million | -338 Thousand | 2.25 Million |
| Other Financing Activities | 24 Thousand | - | 17.57 Million | 5.46 Million | -338 Thousand | 2.25 Million |
| Accounts receivables | 7000.00 | 440 Thousand | 125 Thousand | 547 Thousand | -482 Thousand | 39 Thousand |
| Accounts payables | 109 Thousand | -259 Thousand | -3.45 Million | -693 Thousand | 69 Thousand | -3.17 Million |
| Inventory | 64 Thousand | 320 Thousand | -465 Thousand | -772 Thousand | 31 Thousand | 168 Thousand |
| Other working capital | 78 Thousand | -47 Thousand | -337 Thousand | 157 Thousand | 164 Thousand | -138 Thousand |
| Cash at beginning of period | 2.47 Million | 4.55 Million | 3.95 Million | 1.54 Million | 4.66 Million | 9.08 Million |
| Cash at end of period | 1.15 Million | 2.47 Million | 4.55 Million | 4.55 Million | 1.54 Million | 4.66 Million |
| Capital Expenditure | - | - | -43 Thousand | - | - | -36 Thousand |
| Effect of forex changes on cash | 7000.00 | -8000.00 | - | 6000.00 | - | -1000.00 |
| Net cash flow / Change in cash | -1.32 Million | -2.08 Million | 604 Thousand | 3.01 Million | -3.11 Million | -4.41 Million |
| Free Cash Flow | -1.35 Million | -2.07 Million | -17 Million | -2.45 Million | -2.78 Million | -6.69 Million |
BYAN
002374
6790
LANDO
ALSEA
VISL